baber/WOPTO huggingface dataset:
Patent AU-708253-B2 (AU)
Title: Phosphinic acid derivatives, their preparation and their use
Inventor: PEYMANN ANUSCHIRWAN
IPC: C07F9/6584
Filed: 1995-06-28
Granted: 1999-07-29
Abstract: Cyclic phosphinic acid derivs. of formula (I) are new: A = gp. of formulae (a) or (b); n = 0 or 1; Y, R<1> = O or S; R<2> = H, alkyl, alkenyl, etc.; R<3>, R<3>* = H, NH2, alkyl, etc.; or R<3>+R<3>* = 3-6 membered ring opt. contg. 1-3 heteroatoms, e.g. O or N; G, F = H, F, Cl, Br, OH or R<4>; but F = H when G = OH; R<4> = H, 1-20C acyl, or OH pro-drug gp.; B = e.g. -C(L)-; L = e.g. O; D, D* = H, 1-20C Alk<1>, R<6> or R<6>-(1-6C Alk<1>); Alk<1> = satd., mono- or multiply-unsatd. or cyclic alkyl, etc.; R<6> = satd., unsatd. or partly unsatd. 3-35C isocyclic or heterocyclic ring system contg. 3-9 membered rings, etc.; E, E* = H, satd. or unsatd. 1-7C alkyl opt. mono-, di- or tri-substd. by F, Cl, Br or 1-3C alkoxy, etc..
Patent AU-779855-B2 (AU)
Title: Novel compounds and compositions as protease inhibitors
Inventor: OBALLA RENATA MARCELLA
IPC: A61P19/10
Filed: 2001-01-05
Granted: 2005-02-17
Abstract: The present invention relates to novel cysteine protease inhibitors of Formula I:the pharmaceutically acceptable salts and N-oxide derivatives thereof, their use as therapeutic agents and methods of making them.
Patent AU-550894-B2 (AU)
Title: Cationic softener compositions
Inventor: BUTTERWORTH ROBERT MICHAEL
IPC: C11D3/20
Filed: 1984-04-06
Granted: 1986-04-10
Abstract: A liquid fabric softening composition contains(i) an aqueous base;(ii) awater-insoluble cationic fabric softener such as a quaternary ammonium salt or an imidazolinium salt;(iii) a nonionic material having an HLB of not more than 10 such as fatty acids, fatty esters of monohydric or polyhydric alcohols and fatty alcohols, the ratio of the cationic to nonionic materials being less than 5:1; and(iv) an electrolyte selected from salts of lithium, calcium, magnesium and aluminium.The specified electrolytes improve the stability of the composition.
Patent AU-685956-B2 (AU)
Title: Process for the preparation of diesters of phosphonocarboxylic acid derivatives
Inventor: DERMEIK SALMAN DR
IPC: B01J31/02
Filed: 1995-07-28
Granted: 1998-01-29
Abstract: Prepn. of phosphono cpds. (I) of formula (A) (R<1>O)(R<2>O)P(=O)Z (A) where Z = CH(X)-CH2-Y, comprises reacting a phosphite (II) of formula A where Z = H, with an ethylenically unsatd. cpd. of formula (III) X-CH=CH-Y (III) in the presence of both a basic catalyst of formula (IV) MOR<3> (IV) and a divalent metal halide or (hydr)oxide, where in all these formulae R<1>, R<2> = 1-4C alkyl or phenyl, opt. with Cl or Br substit(s).; X = H or Me; Y = -COOR<1>, -CONH2, -CONHR<1>, -CONR<1>2 or -C=N; M = an alkali metal, pref. Na or K; R<3> = as R<1>, pref. unsubstd. alkyl, esp. Me or Et.
Patent AU-727909-B2 (AU)
Title: Mid-chain branched surfactants
Inventor: CONNOR DANIEL STEDMAN
IPC: C11D1/65
Filed: 1997-04-16
Granted: 2001-01-04
Abstract: Mid-chain branched surfactants derived from mid-chain branched primary alkyl hydrophobic groups and hydrophilic groups. The present invention also relates to mixtures of mid-chain branched surfactants useful in laundry and cleaning compositions, especially granular and liquid detergent compositions.
Patent AU-699501-B2 (AU)
Title: Novel thrombin inhibitors, the preparation and use thereof
Inventor: BOHM HANS-JOACHIM
IPC: C07D207/48
Filed: 1995-06-06
Granted: 1998-12-03
Abstract: Compounds of the formula and the salts thereof with physiologically tolerated acids and the stereoisomers thereof, in which the substituents have the meanings stated in the description, are described. Also disclosed are intermediates for their preparation. The compounds are suitable for controlling diseases.
Patent AU-782263-B2 (AU)
Title: Tissue-specific expression of target genes in plants
Inventor: GOOD ALLEN G
IPC: C12N9/10
Filed: 2001-01-29
Granted: 2005-07-14
Abstract: Methods of producing plants having tissue-specific expression of one or more target genes are taught, as are methods of producing plants having tissue-specific and environmental or developmentally-regulated expression of one or more target genes. A genetic construct is taught which contains a nitrogen assimilation and/or metabolism gene and a promoter for the gene which is inducible under conditions where it would be beneficial to take up, store or use nitrogen. The promoter can be, for example, induced by the presence of nitrate or other form of nitrogen and will be induced by application of a nitrogenous fertilizer. The stress inducible promoter btg-26 is also taught. Promoter btg-26 is isolated from the <i>Brassica</i> turgor gene - 26 and exhibits osmotic-stress induced and tissue-specific expression of an operatively linked gene. The present invention also provides for methods to produce plants with increased biomass and seed yield.
Patent AU-761489-B2 (AU)
Title: Method and apparatus for time tracking
Inventor: LEVIN JEFFREY A
IPC: H04B1/7085
Filed: 2000-02-08
Granted: 2003-06-05
Abstract: In order to time track an incoming signal, a receiver demodulates a first instance of a signal to produce a first set of energy values corresponding to a set of possible data values of the signal. The receiver also demodulates a second instance of the signal to produce a second set of energy values corresponding to the set of possible data values. The receiver combines the first and the second sets of energy values to determine a combined set of energy values. The receiver determines a first estimate of a most likely transmitted data value based upon the combined set of energy values. The receiver decovers an early set of despread samples of the first instance using a symbol corresponding to the first estimate to produce a first early energy value. The receiver decovers a late set of despread samples of the first instance using the symbol corresponding to the first estimate to produce a first late energy value. Finally, the receiver determines a time offset of the first instance based upon the first early and the first late energy values.
Patent AU-561732-B2 (AU)
Title: Optical fibre ribbon structure
Inventor: TAYLOR JOHN EDWARD
IPC: G02B6/04
Filed: 1984-06-15
Granted: 1987-05-14
Abstract: An optical fibre ribbon structure suitable for use in an optical cable or other application where there is a risk that optical fibres will be subjected to a tensile force comprises a plurality of optical fibres (1) and flexible reinforcing elements (2) of resilient material arranged side by side and embedded in an elongate plastics body (3). Each resilient reinforcing element (2) is set in such a form that the ribbon structure follows a path of smoothly curved undulations (4) whose axes of curvature lie parallel to one another and normal to the longitudinal axis of the ribbon structure. When the undulating ribbon structure is subjected to a tensile force, the ribbon structure straightens in a lengthwise direction against the action of the resilient reinforcing elements thereby reducing the tensile force otherwise applied to the optical fibres (1). When the tensile force is removed, the ribbon structure returns towards its original undulating form.
Patent AU-619245-B2 (AU)
Title: Machine and method for sorting out fines and over-thick wood chips
Inventor: ARTIANO ADRIAN
IPC: D21B1/02
Filed: 1989-02-03
Granted: 1992-01-23
Abstract: Wood chips having an acceptable thickness pass between the rollers of a roller screen for collection and over-thick chips discharge from one end of the roller screen for recycling. The rollers have chip agitating protuberances, preferably of pyramidal shape or in the form of spiral ridges. A second roller screen with pyramidal protuberances on its rollers and with its rollers closer together is used to screen out fines, preferably after the fines and acceptable chips pass through the first roller screen. Some of the fines pass through the second roller screen by occupying the valleys between the pyramidal protuberances.
Patent AU-708432-B2 (AU)
Title: Method and apparatus for automatically shuffling cards
Inventor: BREEDING JOHN G
IPC: A63F1/12
Filed: 1995-07-28
Granted: 1999-08-05
Abstract: The present invention provides a machine for shuffling multiple decks of playing cards including a first vertically extending magazine for holding a stack of unshuffled playing cards, and second and third vertically extending magazines each for holding a stack of cards, the second and third magazines being horizontally spaced from and adjacent to the first magazine. A first card mover is at the top of the first magazine for moving cards from the top of the stack of cards in the first magazine to the second and third magazines to cut the stack of unshuffled playing cards into two unshuffled stacks. Second and third card movers are at the top of the second and third magazines, respectively, for randomly moving cards from the top of the stack of cards in the second and third magazines, respectively, back to the first magazine, thereby interleaving the cards to form a vertically registered stack of shuffled cards in the first magazine.
Patent AU-560646-B2 (AU)
Title: Poppet valve with float function
Inventor: KRAEMER KENNETH DEE
IPC: F15B13/042
Filed: 1984-08-31
Granted: 1987-04-09
Abstract: A four-function valve for operating a 2-way hydraulic cylinder has a pair of solenoid-operated pilots. The valve also includes a pair of valve members and a pair of poppet members, all slidable within bores in a pair of hollow sleeves. The solenoid-operated pilot valves control pilot pressure communication to the valve members to control movement of the valve and poppet members. Each poppet member has a pair of seats, one engageable with a shoulder on the sleeve to control fluid flow between a pump and the cylinder, the other engageable with an end of the corresponding valve member to control fluid flow between a sump and the cylinder.
Patent AU-778957-B2 (AU)
Title: Bacterial membrane fractions with adjuvant effect
Inventor: LIBON CHRISTINE
IPC: A61K35/74
Filed: 2000-03-15
Granted: 2004-12-23
Abstract: The invention concerns the use of a membrane fraction of gram-negative bacteria, in particular Klebsiella pneumoniae combined with an antigen or hapten for preparing a pharmaceutical composition designed to direct the immune response towards a Th1 and/or a mixed Th1/Th2 type response directed against said antigen or hapten. The invention further concerns methods for preparing said membrane fractions and pharmaceutical compositions containing them and their uses for preventing and treating infectious diseases, in particular those involving paramyxovirus such as VRS, and cancers, in particular those with tumour-associated antigens.
Patent AU-686449-B2 (AU)
Title: Control device for pointing
Inventor: STROMBERG ROLF
IPC: G06F3/039
Filed: 1995-08-17
Granted: 1998-02-05
Abstract: PCT No. PCT/SE95/00939 Sec. 371 Date Feb. 25, 1997 Sec. 102(e) Date Feb. 25, 1997 PCT Filed Aug. 17, 1995 PCT Pub. No. WO96/07159 PCT Pub. Date Mar. 7, 1996A control device comprises a rotatable and translatable bar for controlling a pointing device such as a mouse or mouse-pen associated with the control device. A key for the clicking function is also provided. It is possible to adjust the control device for different types of pointing devices and a friction reducing system is also described.
Patent AU-714656-B2 (AU)
Title: Recording paper, and image forming method employing the same
Inventor: SAKAKI MAMORU
IPC: D21H11/14
Filed: 1995-10-26
Granted: 2000-01-06
Abstract: A recording paper formed mainly from a fibrous material with a cationic substance applied onto the surface thereof or impregnated therein contains a non-wood fiber at least. An image forming method comprises forming an image on the recording paper through steps of developing an electrostatic image on a photosensitive member by a developing means with a toner, transferring the developed toner image from the photosensitive member onto the recording paper, and fixing the transferred toner image on the recording paper. An image forming method comprises forming an image on the recording paper by ink-jet recording by applying, onto the recording paper, droplets of an ink containing at least an acid dye and/or a direct dye, water, and a water-soluble solvent. <IMAGE>
Patent AU-666520-B2 (AU)
Title: Fire retardant entangled polyester nonwoven fabric
Inventor: HUGHES ALFRED J
IPC: D04H1/46
Filed: 1993-03-10
Granted: 1996-02-15
Abstract: An entangled polyester fiber nonwoven fabric with balanced tensile strength properties and with a fire retardancy in both the machine and cross machine directions of greater than 20 secs. when measured in accordance with NFPA Test No. 702. <IMAGE>
Patent AU-658722-B2 (AU)
Title: Controlling atmospheres in containers
Inventor: GARRETT MICHAEL ERNEST
IPC: B65D85/50
Filed: 1993-03-23
Granted: 1995-04-27
Abstract: A system for controlling the atmosphere in a container comprises a plurality of separate but inter-communicating adsorbent beds arranged in series for the selective adsorption of any water vapour, ethylene, carbon dioxide and oxygen present in the atmosphere and valve means for controlling the flow of atmosphere between successive adsorbent beds. <IMAGE>
Patent AU-702593-B2 (AU)
Title: Matrix for transdermal drug delivery
Inventor: GARBE JAMES E
IPC: C08L55/00
Filed: 1995-09-12
Granted: 1999-02-25
Abstract: A transdermal drug delivery device involving a macromonomer-containing acrylate or methacrylate copolymer, a softener, and a drug. Also a pressure sensitive skin adhesive involving a macromonomer containing acrylate or methacrylate copolymer and a softener.
Patent AU-665248-B2 (AU)
Title: Collection bags and method for producing such bags
Inventor: ENEVOLDSEN JOHN
IPC: A61F5/445
Filed: 1993-03-03
Granted: 1995-12-21
Abstract: Collection bags for use by urine-incontinent or ostomy-operated individuals, comprising two outer sheet walls, an inlet opening and optionally one or more discharge openings, wherein the two outer sheet walls have interposed between them one or more inner sheet members which are joined with the outer sheet walls and wherein at least one of the inner sheet members has at least one fold between a joint to the inner side of the one and the other outer sheet wall, respectively, when the bag is empty. Processes for producing the collection bags by welding in one or two steps and using temporary or permanent welding-preventing elements. The collection bags have a substantially flat shape and a substantially plane surface, so that the area extent of the bag is utilized optimally in terms of volume.
Patent AU-628833-B2 (AU)
Title: A mixing valve arrangement
Inventor: ORLANDI ALESSIO
IPC: F16K11/00
Filed: 1989-08-02
Granted: 1992-09-24
Abstract: Locking device to fit a mixing valve for hot and cold water into the body (11) of a tap, in particular a locking nut (20) bearing on the cover (14) of cardridge the body (42) of the mixing valve by interposing suitable elastic means (21) to compensate eventual plays and distribute the locking load.
Patent AU-622470-B2 (AU)
Title: 13,17-propionic acid and propionic acid derivative substituted porphyrin complex compounds, process for their production and pharmaceutical agents containing them
Inventor: NIEDBALLA ULRICH DR
IPC: C07D487/22
Filed: 1989-08-11
Granted: 1992-04-09
Abstract: Porphyrin complex compounds consisting of at least one porphyrin ligand, optionally at least one ion of an element of atomic numbers 5, 13, 21-32, 37-39, 42-44, 49, 50 or 57-83 as well as optionally cations of inorganic and/or organic bases, amino acids or amino acid amides, are valuable diagnostic media and therapeutic agents.
Patent AU-697378-B2 (AU)
Title: Antibiotic cryptdin peptides and methods of their use
Inventor: SELSTED MICHAEL E
IPC: G01N33/564
Filed: 1995-10-05
Granted: 1998-10-01
Abstract: The present invention provides substantially purified cryptdin peptides having a consensus amino acid sequence:wherein X1 is 3 to 9 amino acids; X2 is one amino acid, preferably Y, H or R; X3 is 2 or 3 amino acids; X4 is three amino acids; X5 is five amino acids; X6 is 6 to 10 amino acids; and X7 is 0 to 9 amino acids. The invention also provides a substantially purified mouse cryptdin having a consensus amino acid sequence:wherein X1 is 3 or 4 amino acids, preferably LRD, LSKK (SEQ ID NO: 1) or LRG; X2 is 1 amino acid, preferably V, L or I; X3 is 3 amino acids, preferably KGH or *RG, where * is S, T, K, I or A; X4 is 2 amino acids, preferably GR, RR or RG; X5 is 3 amino acids, preferably RMN, RVR, RVF HMN or HIN; X6 is 6 to 9 amino acids, preferably GIRFLY (SEQ ID NO: 2) or RNLFLTFVF (SEO ID NO: 3), RRGHLMYTL (SEQ ID NO: 4) or RKGHL*YT* (SEQ ID NO: 5), where * independently is L or M; and X7 is 0 to 3 amino acids, preferably R, S or PRR. The invention also provides cryptdin analogs, which are devoid of one or more amino acids N-terminal to the first cysteine. In addition, the invention provides nucleic acid molecules encoding cryptdin peptides. The invention further provides methods for detecting inflammatory pathologies in a subject and for treating an inflammatory pathology in a subject by administering a pharmaceutical composition containing a cryptdin peptide.
Patent AU-729149-B2 (AU)
Title: Process for the production of drospirenone (6beta 7beta; 15beta, 16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21, 17- carbolactone,DRSP) and 7alpha-(3-hydroxy-1-proply)-6beta, 7beta; 15beta, 16beta-dimethylene-5beta-androstane-3beta,5, 17beta-triol (ZK 92836) and 6beta, 7beta; 15beta, 16beta- dimethylene-5beta-hydroxy-3-oxo-17alpha-androstane-21,17- caarbolactone (90965) as intermediate products of the process
Inventor: MOHR JORG-THORSTEN
IPC: C07J53/00
Filed: 1997-08-11
Granted: 2001-01-25
Abstract: Production of drospirenone (6beta ,7beta ;15beta ,16beta -dimethylene-3-oxo-17alpha -pregn-4-ene-21,17-carbolactone) of formula (I) comprises catalytically hydrogenating 17alpha -(3-hydroxy-1-propynyl)-6beta ,7beta ;15beta ,16beta -dimethylene-5beta -androstane-3beta ,5,17beta -triol of formula (II) to give 17alpha -(3-hydroxypropyl)-6beta ,7beta ;15beta ,16beta -dimethylene-5beta -androstane-3beta ,5,17beta -triol of formula (III), oxidising (III) in the presence of a ruthenium salt to give 6beta ,7beta ;15beta ,16beta -dimethylene-5beta -hydroxy-3-oxo-17alpha -pregnane-21,17-carbolactone of formula (IV), and dehydrating (IV): Also claimed are intermediates (III) and (IV).
Patent AU-630370-B2 (AU)
Title: Pharmaceutical preparations which can be applied transdermally, containing sterolins and/or spiroketalins
Inventor: WALKER HANS DR
IPC: A61K47/28
Filed: 1989-09-01
Granted: 1992-10-29
Abstract: The invention relates to novel, transdermally applicable pharmaceutical preparations including sterolines or spiroketalines, a solvent selected from the group consisting of ethoxylated sterols and C12-C30 alcohols, and lipophilic ointment base. Methods of treatment using same.
Patent AU-623464-B2 (AU)
Title: Zeolites
Inventor: CASCI JOHN LEONELLO
IPC: C01B39/26
Filed: 1989-12-21
Granted: 1992-05-14
Abstract: A zeolite, NU-87 has in its "as-prepared" form an X-ray diffraction pattern including the following lines: <CHEM>   It is prepared from a reaction mixture containing sources of silica, a polymethylene alpha, omega-diammonium cation and optionally sources of alumina and metal oxide.
Patent AU-682315-B2 (AU)
Title: Communication channel switching arrangement
Inventor: LEEUW LUC VAN
IPC: H04M3/30
Filed: 1993-08-13
Granted: 1997-10-02
Abstract: PCT No. PCT/GB93/01717 Sec. 371 Date Feb. 24, 1995 Sec. 102(e) Date Feb. 24, 1995 PCT Filed Aug. 13, 1993 PCT Pub. No. WO94/05108 PCT Pub. Date Mar. 3, 1994A maintenance termination unit (MTU) for use in telephone circuits. The MTU comprises a switching arrangement which can be connected in a communications channel, the communications channel comprising a pair of lines. The switching arrangement is connected between a set of exchange-side terminal equipment and a set of subscriber-side terminal equipment. The arrangement comprises first and second line switches, each of which is series connected in one of the lines. Each line switch comprises a control terminal, and has a closed state in which it will pass normal line current, and an open state in which it will pass at most a reduced line current. The arrangement also comprises a control circuit which is connected to the channel between the line switches and the subscriber-side terminal equipment. The control circuit comprises: a charge reservoir which is connected between the lines; a reservoir charging switch which is connected in series with the charge reservoir and controls the charging of the reservoir in response to a signal on the lines; and a reservoir discharging switch which is controlled by a signal on the lines and will allow the reservoir, when charged, to energize the control terminals of the line switches so that, when the line switches are opened by the control circuit, the line switches can be maintained in an open state for a period of time by discharging the reservoir.
Patent AU-631594-B2 (AU)
Title: Non-tin-based, low toxicity anti-fouling agents
IPC: C09D5/16
Filed: 1989-12-20
Granted: 1992-12-03
Abstract: Disclosed are marine anti-fouling compositions, such as coating compositions, of a thermoplastic or thermoset binder, solvent, and anti-fouling agent wherein the anti-fouling agent comprises a pesticide or herbicide having a  chi  value of between about 0.01 and 0.5, a Z parameter for vinyl or aromatic compounds of between about 0.01 and 0.08, and an LD50 value of greater than 200 mg/kg against rats and mice.
Patent AU-628918-B2 (AU)
Title: Microwave heating by means of a modified energy field including higher order modes
Inventor: KEEFER RICHARD M
IPC: H05B6/74
Filed: 1990-02-08
Granted: 1992-09-24
Abstract: A method and device for enhancing the heating of a surface layer (426) of an article being heated by microwave energy (E) is characterised by directing the energy through the surface layer into a main portion (427) of the article in such a manner that the modes of the energy (E min ) are in cut-off in the surface layer.
Patent AU-769201-B2 (AU)
Title: Fluorescent intensity method for assaying binding between proteins or peptides
Inventor: ERIKSON GLEN H
IPC: G01N33/566
Filed: 2000-06-20
Granted: 2004-01-22
Abstract: A method for assaying specific binding between a fluorophore-labeled probe and an unlabeled target is provided. The method includes detecting a quenching effect on fluorescence emitted by the fluorophore-labeled probe resulting from binding. The method is conducted without separating complexes of the target and probe from the free target and free probe prior to quenching effect detecting, and without providing a signal quenching agent to quench fluorescent light. Preferably, the probe and target are amino acid-containing compounds, such as proteins. The method can be used for a variety of applications, including screening for drug candidates having optimum binding properties, and quantifying and classifying the binding characteristics between peptide-containing compounds. The method is more sensitive than conventional assays, enabling the analysis of minute samples and low affinity binding interactions between receptors and ligands that are below the detection limits of conventional technology.
Patent AU-767294-B2 (AU)
Title: Use of magnesium (Mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy
Inventor: BRAUN SERGE
IPC: A61K31/7088
Filed: 1999-09-29
Granted: 2003-11-06
Abstract: Described is the use of magnesium (Mg<2+>) for the preparation of a therapeutic composition for the introduction of a polynucleotide into a cell in vivo.